| 30.86 -1.97 (-6%) | 03-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 38.8 |
1-year : | 41.55 |
| Resists | First : | 33.22 |
Second : | 35.58 |
| Pivot price | 32.59 |
|||
| Supports | First : | 29.42 |
Second : | 24.47 |
| MAs | MA(5) : | 32.38 |
MA(20) : | 33.03 |
| MA(100) : | 32.91  |
MA(250) : | 23.02 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 43.7 |
D(3) : | 46.5 |
| RSI | RSI(14): 36.4 |
|||
| 52-week | High : | 38 | Low : | 8.64 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ INDV ] has closed above bottom band by 1.4%. Bollinger Bands are 17.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 31.52 - 31.69 | 31.69 - 31.84 |
| Low: | 29.02 - 29.23 | 29.23 - 29.4 |
| Close: | 30.54 - 30.86 | 30.86 - 31.14 |
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
Fri, 13 Mar 2026
Indivior Pharmaceuticals prices upsized $450M convertible senior notes - MSN
Fri, 13 Mar 2026
Indivior plans $400 million convertible notes offering By Investing.com - Investing.com India
Thu, 12 Mar 2026
Indivior (INDV) Plans $400 Million Convertible Notes Offering - GuruFocus
Thu, 12 Mar 2026
Indivior prices $450 million convertible notes offering - Investing.com
Thu, 12 Mar 2026
Indivior Pharmaceuticals Announces Pricing of $450 Million Convertible Senior Notes Offering - Quiver Quantitative
Thu, 12 Mar 2026
Indivior proposes $400M convertible senior notes due 2031 to refinance debt, fund buybacks - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 125 (M) |
| Shares Float | 107 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 86.4 (%) |
| Shares Short | 11,070 (K) |
| Shares Short P.Month | 11,700 (K) |
| EPS | 0.98 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.78 |
| Profit Margin | 16.9 % |
| Operating Margin | 37.1 % |
| Return on Assets (ttm) | 19.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 19.7 % |
| Gross Profit (p.s.) | 8.31 |
| Sales Per Share | 9.91 |
| EBITDA (p.s.) | 3.17 |
| Qtrly Earnings Growth | 376.2 % |
| Operating Cash Flow | -27 (M) |
| Levered Free Cash Flow | 222 (M) |
| PE Ratio | 31.48 |
| PEG Ratio | 0 |
| Price to Book value | -39.57 |
| Price to Sales | 3.11 |
| Price to Cash Flow | -142.9 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|